Scapa Tapes North America, LLC
FDA inspection history in Knoxville, Tennessee, 2022 to 2025
- 2
- Form 483s
Every document, by year
- Form 483
2022: one Form 483; 2025: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One Form 483, at Knoxville, Tennessee.
- 2025One Form 483, at Knoxville, Tennessee.
- 2025The longest 483 on file: 4 observations over 3 pages at Knoxville, Tennessee.
Cited most
Across all Scapa Tapes North America observations on file
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160(a)General requirements1
- 21 CFR 211.22(d)Responsibilities of quality control unit1
- 21 CFR 820.181Device master record1
The complete Scapa Tapes North America file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Knoxville, Tennessee
Two Form 483s · 2022 to 2025 · 5 observations
Latest: Form 483, Jan 23, 2025 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-01-23 | 483 Form 483 | Knoxville, Tennessee | 4 | $99 |
| 2022-06-17 | 483 Form 483 | Knoxville, Tennessee | 1 | $99 |
Investigators on these documents
Benjamin E. Bowen (1)Christina L. Bigham (1)Mickell Smith (1)Ronda R. Loyd Jones (1)
FEI number 3015200795 · most recent document Jan 23, 2025
About Scapa Tapes North America, LLC
How many FDA Form 483s has Scapa Tapes North America, LLC received?
FDA Intel has 2 Form 483s on file for Scapa Tapes North America, LLC; the most recent is dated Jan 23, 2025.
When was Scapa Tapes North America, LLC last inspected by FDA?
The most recent FDA inspection document on file for Scapa Tapes North America, LLC is a Form 483 dated Jan 23, 2025, for the site in Knoxville, Tennessee.
What did FDA cite at Scapa Tapes North America, LLC?
The regulations cited most in the observations on file for Scapa Tapes North America, LLC are 21 CFR 211.100(a) (Written procedures; deviations), 1 time; 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.160(a) (General requirements), 1 time.